Skip to content

Other

orciprenaline

CAS 586-06-1
20

Safety score · 0–100

Caution

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

Orciprenaline is a cosmetic ingredient used in product formulations. Exercise caution due to limited available safety data.

Orciprenaline (metaproterenol) is a non-selective beta-adrenergic agonist used as a bronchodilator for asthma and COPD, with pharmacological activity similar to isoprenaline. It carries risks of cardiovascular side effects including tachycardia. As a prescription pharmaceutical substance with no cosmetic regulatory history, it is excluded from EU cosmetics regulation scope. No REACH registration or SCCS evaluation exists for cosmetic applications.

Known concerns

  • Beta-adrenergic bronchodilator drug incompatible with cosmetics
  • Cardiovascular side effects including tachycardia
  • No EU cosmetics authorization or SCCS evaluation
  • Outside scope of cosmetics regulation

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Related others

Check your shelf

Find orciprenaline in your products.

Scan any cosmetic product with LuxSense to see if it contains orciprenaline and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.